Impaired Growth during Childhood in Patients with Primary Ciliary Dyskinesia

Tamara Svobodová1, Jana Djakow1, Daniela Zemková1

  • 1Department of Pediatrics, 2nd Faculty of Medicine, University Hospital Motol, Charles University, 150 06 Prague, Czech Republic.

Insights

Primary ciliary dyskinesia (PCD) causes chronic respiratory infections and significant growth delays in children. This study found children with PCD experience progressive height deterioration, particularly those with DNAH5 or DNAI1 mutations.

Area of Science:

  • Pediatrics
  • Genetics
  • Pulmonology

Background:

  • Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by impaired ciliary function.
  • PCD leads to recurrent respiratory infections, chronic inflammation, and potential development of chronic pulmonary disease and bronchiectasis.
  • Growth delay and nutritional deficits are potential complications of chronic childhood illnesses.

Purpose of the Study:

  • To analyze longitudinal growth patterns (height and BMI) in children and young adults diagnosed with Primary Ciliary Dyskinesia (PCD).
  • To investigate the relationship between PCD, genetic mutations (DNAH5, DNAI1), and growth deterioration.
  • To determine if nutritional deficits contribute to growth delay in PCD patients.

Main Methods:

  • Longitudinal data analysis of body length/height and BMI in 29 children and young adults with PCD (ages 1.5-24 years).
  • Diagnosis ages ranged from 0.5-17 years.
  • Genetic analysis was performed on a subset of patients, with 10 carrying mutations in DNAH5 or DNAI1.

Main Results:

  • Children with PCD showed a progressive decrease in height standard deviation scores (SDS) from age 1 to 13 years (P=0.01 to P=0.005).
  • Height deterioration was more pronounced in patients with DNAH5 or DNAI1 mutations.
  • Body Mass Index (BMI) remained within population standards, suggesting growth delay is not due to nutritional deficits.

Conclusions:

  • Primary ciliary dyskinesia (PCD) is associated with significant growth deterioration during childhood.
  • The observed growth delay in PCD is likely a consequence of chronic illness rather than nutritional deficits.
  • Genetic factors, specifically DNAH5 and DNAI1 mutations, may influence the severity of growth impairment in PCD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
1.5K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K